Skip to content

Effect of Endurance Training-Induced Coenzyme Q10 (CoQ10) Supplementation on Myokine, Exerkine Secretion and Cognitive Functions in Long-Distance Runners

Effect of Endurance Training-Induced Coenzyme Q10 (CoQ10) Supplementation on Myokine, Exerkine Secretion and Cognitive Functions in Long-Distance Runners

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06619249
Enrollment
24
Registered
2024-10-01
Start date
2024-08-23
Completion date
2026-07-30
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Knowledge, Attitudes, Practice

Keywords

Coenzyme Q10, Supplementation, Myokine, Exerkine, Cognition, Long-distance runners

Brief summary

The goal of this clinical trial is to learn if CoQ10 amplifies endurance training-induced myokine and exerkine secretion and if those changes influences cognition in long-distance runners. Does 4-week high-dosage CoQ10 supplementation increase the secretion of myokine, exerkine sercetion? Does the above-mentioned intervention improve the cognitive function in long distance runners? Participants will: Take CoQ10 or a placebo every day for 4 weeks. Visit the laboratory once every 4 weeks for checkups and tests. Keep the participants' food and training diary.

Interventions

DIETARY_SUPPLEMENTCoQ10 supplementation

Long-distance runners will be supplemented with CoQ10 for 4 weeks in cross-over manner with 4 weeks of wash out period.

DIETARY_SUPPLEMENTPlacebo supplementation

Long-distance runners will be supplemented with placebo for 4 weeks in cross-over manner with 4 weeks of wash out period.

Sponsors

Gdansk University of Physical Education and Sport
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

A randomized, double-blind, placebo-controlled, cross-over study

Eligibility

Sex/Gender
MALE
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* training experienced for minimum 2 years * running training at least 2 times per week * Personal Best on 10k (\<50 minutes)

Exclusion criteria

* taking supplements which can interrupt primary outcomes (vitamin D, omega-3 fatty acids) * injured in last 6 months to avoid n number reduction

Design outcomes

Primary

MeasureTime frameDescription
Change in cognitive funtions as a result of CoQ10 supplementation measured via cogntitive function test.The investigators are going to check this hypothesis after 4 weeks of high-dose supplementation with CoQ10The investigators assume that supplementation with CoQ10 will change cognition (measured via cognitive function tests - Stroop Test, Trial Making Test A and Trial Making Test B) in long-distance runners. The results will be obtained as time (seconds) needed to complete tasks while testing.
Change in myokine and exerkine concentration in the blood plasma as a result of CoQ10 supplementation.The investigators are going to check this hypothesis after 4 weeks of high-dose supplementation with CoQ10The investigators will assess the concentration of blood myokine and exerkine concentration (pg or ug/dl) of blood plasma using the colorimetric method.

Secondary

MeasureTime frameDescription
Change in aerobic capacity measured via direct test to volitional exhaustion on a motorized treadmillThe investigators are going to check this hypothesis after 4 weeks of high-dose supplementation with CoQ10The investigators assume that supplementation with CoQ10 will change the aerobic capacity (oxygen uptake in ml-1 x min-1 x kg-1) in long-distance runners. The determination of aerobic capacity will be done through progressive test to volitional exhaustion on a motorized treadmill and gas analyzer

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026